Congresswoman Speier to Join Numerate in Announcing U.S. Department of Defense Contract for Speeding Design of Biowarfare Countermeasures

Document Sample
Congresswoman Speier to Join Numerate in Announcing U.S. Department of Defense Contract for Speeding Design of Biowarfare Countermeasures Powered By Docstoc
					Congresswoman Speier to Join Numerate in
Announcing U.S. Department of Defense Contract
for Speeding Design of Biowarfare
Countermeasures
September 07, 2010 10:33 AM Eastern Daylight Time  

SAN BRUNO, Calif.--(EON: Enhanced Online News)--Numerate, Inc., a technology platform company that is
leveraging proprietary algorithms and the power of cloud computing to radically transform the drug design process,
will announce the award of a three-year contract by the Department of Defense through its Transformational Medical
Technologies (TMT) Program. Numerate may receive up to $6.75 million under this new Defense Threat Reduction
Agency (DTRA) contract to extend its pioneering data-driven drug design approach, applying modern machine-
learning methods similar to those employed by Google, Amazon and Netflix to rapidly design new drugs with
optimized safety, efficacy and dosing convenience.

WHO:   Congresswoman Jackie Speier
       Jeremy Leffler, Bay Bio Chief Operating Officer
       Guido Lanza, Numerate Chief Executive Officer
       Nigel Duffy, Numerate Chief Technology Officer
WHAT: Press conference announcing award of DTRA contract to Numerate
WHERE: Numerate headquarters, 1150 Bayhill Drive, Suite 203, San Bruno, CA
WHEN: Thursday, September 9, 2010, from 11:30 a.m. to 12 noon.
       Presenters will provide brief overview of company technology, potential significance to healthcare
       industry, and importance of biotech innovation, both locally and nationally.

Background

Numerate is a privately held biotechnology company focused on making the drug design process more data-driven,
efficient and predictable. Numerate’s technology platform combines advances in computer science and statistics with
traditional medicinal chemistry approaches to address, in parallel, the factors that determine the success and failure of
a drug candidate. Numerate applies this proprietary platform to design and develop small molecule therapeutics in
collaboration with a variety of partners in the pharmaceutical, biotechnology, and academic fields. For more
information, visit www.numerate.com.

For more information about the Defense Threat Reduction Agency and the Transformational Medical Technologies
program, please visit www.dtra.mil and www.tmti-cbdefense.org.

Contacts
for Numerate, Inc.
Carole Melis, 650-342-5686
clmcomm1@gmail.com

Permalink: http://eon.businesswire.com/news/eon/20100907006293/en/Cloud-computing/Defense-Threat-
Reduction-Agency/Department-of-Defense-Contract

				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:1
posted:9/7/2010
language:English
pages:2
Description: SAN BRUNO, Calif.--(EON: Enhanced Online News)--Media Advisory -- Congresswoman Speier will join Numerate in announcing Numerate's award of a three-year contract by the Department of Defense on September 9 at 11:30 a.m. at Numerate headquarters. img border='0' title='Add to Google'
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.